Abstract
Gitelman syndrome represents the clinical manifestations of inactivation of the Slc12a3 genes encoding the thiazide-sensitive sodium chloride cotransporter and the Trpm6-Mg genes encoding the magnesium transporters in the distal convoluted tubule. In fact, the biochemical findings resemble those with thiazide diuretics such as hypokalemia, hypomagnesaemia, hypocalciuria, metabolic alkalosis, and low normal blood pressure. He is usually associated with calcium pyrophosphate deposition. Serum uricemia level is rarely affected in Gitelman syndrome. We aimed to report a rare association of chronic gout with Gitelman syndrome, hence the interest of our case. We describe a 29-year-old male patient with a history of Gitelman syndrome associated with articular gout including pelvic localization. We provided pictorial evidence of extensive and diffuse monosodium urate deposition in articular and periarticular structures to confirm the gout origin. A literature review illustrates 4 reported cases of Gitelman syndrome associated with gout. The gender distribution was equal with a mean age of 40 years.
Key Points • Gouty arthritis and Gitelman syndrome is a rare association. • Gitelman syndrome may be a new risk factor for the development of gout, due to its thiazide-like effect. |
Similar content being viewed by others
Data availability
The data and supportive information is available within the article.
References
Wilson L, Saseen JJ (2016) Gouty Arthritis: A Review of Acute Management and Prevention. Pharmacother J Hum Pharmacol Drug Ther 36:906–922
Richette P, Bardin T (2010) Gout. The Lancet 375:318–328
Ben Salem C, Slim R, Fathallah N, Hmouda H (2017) Drug-induced hyperuricaemia and gout. Rheumatology 56(5):679–688
Pizzorno JE, Murray MT, Joiner-Bey H (2016) Gout. The Clinician’s Handb Nat Med 347–354
Casatta L, Ferraccioli GF, Bartoli E (1997) Hypokalaemic alkalosis, acquired Gitelman’s and Bartter’s syndrome in chronic sialoadenitis. Rheumatology 36:1125–1128
Troster SM, Raizman JE, Rubin L (2016) An Unusual Case of Gout in a Young Woman with Gitelman Syndrome. J Rheumatol 43:2085–2087
Mou L, Wu F (2021) Simultaneous Homozygous Mutations in SLC12A3 and CLCNKB in an Inbred Chinese Pedigree. Genes 12:369
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum 58:26–35
Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol juill 16(7):380–390
Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK (2019) Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey 2007–2016. Arthritis Rheumatol Hoboken NJ juin 71(6):991–999
Girish G, Glazebrook KN, Jacobson JA (2013) Advanced Imaging in Gout. Am J Roentgenol 201:515–525
Tekaya R, Tekaya AB, Saidane O, Said HB, Gaja A, Sahli H et al (2018) Tophaceous hip gouty arthritis revealing asymptomatic axial gout. Egypt Rheumatol 40:209–212
Gitelman HJ, Graham JB, Welt LG (1966) A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79:221–235
Simon DB, Nelson-Williams C, Johnson Bia M, Ellison D, Karet FE, Morey Molina A et al (1996) Gitelman’s variant of Barter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter. Nat Genet 12:24–30
Lemmink HH, Knoers NV, Károlyi L, van Dijk H, Niaudet P, Antignac C et al (1998) Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int 54:720–730
Koçkara AŞ, Candan F, Hüzmeli C, Kayataş M, Alaygut D (2013) Gitelman’s syndrome associated with chondrocalcinosis: a case report. Ren Fail 35:1285–1288
Lin SH, Cheng NL, Hsu YJ, Halperin ML (2004) Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis Off J Natl Kidney Found 43:304–312
Favero M, Calò LA, Schiavon F, Punzi L (2011) Bartter’s and Gitelman’s diseases. Best Pract Res Clin Rheumatol 25:637–648
Cipolletta E, Di Matteo A, Filippucci E, Grassi W (2020) Calcium Pyrophosphate Deposition Disease in a Patient with Familial Hypokalemia-Hypomagnesemia (Gitelman’s-Syndrome): A Case Report - CPPD in Gitelman’s syndrome. Ultraschall Med 41(6):695–697
Chotard E, Blanchard A, Ostertag A, Latourte A, Gailly G, Frochot V et al (2022) Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome. Rheumatology (Oxford) 61(6):2494–2503
Meyer WJ 3rd, Gill JR Jr, Bartter FC (1975) Gout as a complication of Bartter’s syndrome. A possible role for alkalosis in the decreased clearance of uric acid. Ann Intern Med 83:56–59
Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Hada T (2001) An atypical case of primary renal tubular hypokalaemic metabolic alkalosis with chronic tophaceous gout. Clin Rheumatol 20(5):372–375
Shahzad MA, Mukhtar M, Ahmed A, Ullah W, Saeed R, Hamid M (2019) Gitelman Syndrome: A Rare Cause of Seizure Disorder and a Systematic Review. Case Rep Med 2019:1–8
Author information
Authors and Affiliations
Contributions
All the authors contributed to the study conception and design.
Emna Hannech and Riadh Jeribi have made substantial contributions to the conception or design of the work; the acquisition, analysis, and interpretation of data for the work.
Leila Rouached revised the work critically for important intellectual content.
Aicha Ben Tekaya and Selma Bouden have made substantial contributions to the acquisition, analysis, and interpretation of data for the work.
Rawdha Tekaya, Linda Belhaj Kacem, Ines Mahmoud, and Olfa Saidane have given their agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Leila Abdelmoula and Soumaya Rammeh approved the final version to be published.
Corresponding author
Ethics declarations
Ethics approval
Our locally appointed ethics committee “Charles Nicolle Hospital local committee” has approved the research protocol and informed consent has been obtained from the subject.
Human and animal rights
Our study complies with the Declaration of Helsinki.
Informed consent
Written informed consent was obtained from the patient.
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rouached, L., Hannech, E., Jeribi, R. et al. Tophaceous gout in a young man with Gitelman syndrome: a case report with an overview. Clin Rheumatol 42, 285–291 (2023). https://doi.org/10.1007/s10067-022-06361-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06361-2